OtherPublishAheadOfPrint
Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
Claude Nahmias and Lindi M. Wahl
Journal of Nuclear Medicine October 2008, DOI: https://doi.org/10.2967/jnumed.108.054239
This article has a correction. Please see:
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Reproducibility of Standardized Uptake Value Measurements Determined by 18F-FDG PET in Malignant Tumors
Claude Nahmias, Lindi M. Wahl
Journal of Nuclear Medicine Oct 2008, DOI: 10.2967/jnumed.108.054239
Jump to section
Related Articles
Cited By...
- Hot Spot Imaging in Cardiovascular Diseases: An Information Statement from SNMMI, ASNC, and EANM
- 18F-FDG PET/CT-Based Prognostic Survival Model After Surgery for Head and Neck Cancer
- Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors
- Measurement Repeatability of 18F-FDG PET/CT Versus 18F-FDG PET/MRI in Solid Tumors of the Pelvis
- Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
- 18F-FDG PET/CT Can Predict Development of Thyroiditis Due to Immunotherapy for Lung Cancer
- Reproducibility of MR-Based Attenuation Maps in PET/MRI and the Impact on PET Quantification in Lung Cancer
- Test-Retest Variability in Lesion SUV and Lesion SUR in 18F-FDG PET: An Analysis of Data from Two Prospective Multicenter Trials
- Repeatability of SUV in Oncologic 18F-FDG PET
- Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
- Influence of Statistical Fluctuation on Reproducibility and Accuracy of SUVmax and SUVpeak: A Phantom Study
- Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials
- Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non-Small Cell Lung Cancer
- Variability of Total Lesion Glycolysis by 18F-FDG-Positive Tissue Thresholding in Lung Cancer
- Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response
- Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab
- Using FDG-PET to Measure Early Treatment Response in Head and Neck Squamous Cell Carcinoma: Quantifying Intrinsic Variability in Order to Understand Treatment-Induced Change
- Mammary Cancer Bone Metastasis Follow-up Using Multimodal Small-Animal MR and PET Imaging
- 18F-FDG Uptake by Metastatic Axillary Lymph Nodes on Pretreatment PET/CT as a Prognostic Factor for Recurrence in Patients with Invasive Ductal Breast Cancer
- Infection Dynamics and Response to Chemotherapy in a Rabbit Model of Tuberculosis using [18F]2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
- Noise Considerations for PET Quantification Using Maximum and Peak Standardized Uptake Value
- Repeatability of 18F-FDG Uptake Measurements in Tumors: A Metaanalysis
- Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET
- Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response
- 18F-Fluromisonidazole PET Imaging as a Biomarker for the Response to 5,6-Dimethylxanthenone-4-Acetic Acid in Colorectal Xenograft Tumors
- Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements
- Monitoring Response to Antiangiogenic Therapy in Non-Small Cell Lung Cancer Using Imaging Markers Derived from PET and Dynamic Contrast-Enhanced MRI
- Reproducibility of 18F-FDG and 3'-Deoxy-3'-18F-Fluorothymidine PET Tumor Volume Measurements
- Assessment of Interobserver Reproducibility in Quantitative 18F-FDG PET and CT Measurements of Tumor Response to Therapy
- Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal Malignancies
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- Role of 18F-FDG PET in Assessment of Response in Non-Small Cell Lung Cancer